¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sodium channel blocking agent"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • protective agent
    º¸È£Á¦
  • proteolytic agent
    ´Ü¹éÁúºÐÇØÁ¦
  • reducing agent
    ȯ¿øÁ¦, ȯ¿ø½Ã¾à
  • spermicidal agent
    »ìÁ¤ÀÚÁ¦
  • sclerosing agent
    °æÈ­Á¦
  • single-agent chemotherapy
    ´ÜÀÏÁ¦Á¦Ç×¾ÏÈ­Çпä¹ý
  • volatile agent
    Èֹ߼º¾à
  • volatile inhalation agent
    Èֹ߼ºÈíÀÔ¸¶ÃëÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • proteolytic agent
    ´Ü¹éºÐÇØÁ¦
  • reducing agent
    ȯ¿øÁ¦, ȯ¿ø½Ã¾à
  • sclerosing agent
    °æÈ­Á¦
  • skin protective agent
    ÇǺκ¸È£Á¦
  • spermicidal agent
    »ìÁ¤ÀÚÁ¦
  • therapeutic agent
    Ä¡·áÁ¦
  • toxic agent
    µ¶¹°, µ¶±Ø¹°
  • volatile agent
    Èֹ߼º¾à
  • volatile inhalation agent
    Èֹ߼ºÈíÀÔ¸¶ÃëÁ¦
  • single-agent chemotherapy
    ´ÜÀÏÁ¦Á¦Ç×¾ÏÈ­Çпä¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • goitrogenic agent
    °©»ó¼±Á¾¹ß»ýÀÎÀÚ.
  • hepatotoxic agent
    °£µ¶¼º ¹°Áú.
  • hydrotropic agent =emulsifying a.
    À¯È­Á¦(êáûùð¥).
  • hypoglycemic agent
    Ç÷´ç°­ÇϾà.
  • hypotensive agent
    °­¾ÐÁ¦(˽äâð¥).
  • immunosuppresive agent
    ¸é¿ª¾ïÁ¦Á¦
  • immunosuppressive agent
    ¸é¿ª¾ïÁ¦¾à, ¸é¿ª¾ïÁ¦ÀÎÀÚ.
  • immunosuppressive agent
    ¸é¿ª¾ïÁ¦¾à, ¸é¿ª¾ïÁ¦ÀÎÀÚ.
  • induction agent
    À¯µµ¹°Áú
  • infective agent
    °¨¿°ÀÎÀÚ.
  • inotropic agent
    ¼öÃàÃËÁøÁ¦(¡­ð¥).
  • physical agent
    ¹°¸®Àû ÀÎÀÚ(Úª×âîÜ ì×í­)
  • pressor agent
    Ç÷¾Ð»ó½ÂÁ¦.
  • protective agent
    º¸È£¾à, ÇÇÆ÷¾à(̰̰Ëâ).
  • psychedelic agent
    ȯ°¢Á¦.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • phethenylate sodium
    ÆäÅ×´Ò·¹ÀÌÆ®³ªÆ®·ý.
  • simple sodium depletion
    ´Ü¼øNa<³ªÆ®·ý>ºÎÁ·.
  • soda = sodium bicarbonate
  • sodium
    ¼Òµð¿ò
  • sodium
    ³ªÆ®·ý.
  • sodium
    ³ªÆ®·ý(¡­), ¼Òµã(¡­)
  • sodium acetate formalin
    ¾Æ¼¼Æ®»ê³ªÆ®·ý Æ÷¸£¸»¸°
  • sodium balance
    ¼Òµð¿òÆòÇü.
  • sodium bicarbonate test
    ÁßÁ¶½ÃÇè
  • sodium carrier
    ³ªÆ®·ý¿î¹Ýü(¡­ê¡Úæô÷).
  • sodium chloride
    ¿°È­³ªÆ®·ý
  • sodium chloride balance test
    ¿°È­³ªÆ®·ýÆòÇü½ÃÇè(¡­øÁû¬ãËúÐ).
  • sodium chloride poisoning
    ¿°È­³ªÆ®·ýÁßµ¶Áõ(¡­ñéÔ¸ñø).
  • sodium chloride poisoning
    ¿°È­³ªÆ®·ýÁßµ¶Áõ(¡­ñéÔ¸ñø)
  • sodium deficit
    ³ªÆ®·ý°áÇÌ(Áõ)(¡­ÌÀù¹ñø).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
TC target cell; taurocholate; temperature compensation; teratocarcinoma; tertiary cleavage; tetracyclin...
VDAC voltage-dependent anion channel
VOCC voltage-operated calcium channel
DTIC Dimethyl Triazeno Imidazole Carboxamide
  ; Alkylating Agent
HDV Hepatitis D(elta) Virus
  = HBV associated Delta Agent
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
K(Ca) K channel
KCO K+ channel opener
BK(Ca) K(+) channel
PCO potassium channel opener
VOCC Voltage-operated calcium channel
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antitubercular agent
    Ç×°áÇÙÁ¦
  • antituberculous agent
    Ç×°áÇÙ ¾à
  • antitumor agent
    Ç׾Ͼà, Á¦¾Ï ¾à, Ç×Á¾¾ç ¾à, Ç×Á¾¾ç¼º ¾à, Ç×Á¾¾ç ÀÎÀÚ, Ç×Á¾¾ç¼º ÀÎÀÚ
  • bleaching agent
    Ç¥¹éÁ¦
    ¿°·á³ª »ö±òÀ» »©³»´Â È­ÇÐÀû ¾àÁ¦.
  • bonding agent
    °áÇÕÁ¦, Á¢ÂøÁ¦, º»µùÁ¦
    Ä¡Áú°ú ÇÇÁ¢ÀÛ¹°°úÀÇ »çÀÌ¿¡ °³Àç½ÃÄÑ, ¾çÀÚ¸¦ Á¢ÇÕ½ÃŰ´Â Á¢ÇÕÁ¦.
  • buffering agent
    ¿ÏÃæÁ¦
  • bulking agent
    ÃæÀüÁ¦
  • carcinoclastic agent
    Á¦¾Ï ¾à, Ç×¾Ï ¾à
    µ¿ÀǾî=carcinostatic agent.
  • carcinostatic agent
    Á¦¾Ï ¾à
    ¾Ï ¼¼Æ÷ÀÇ Áõ½ÄÀ» ¾ïÁ¦ÇÏ´Â ¼ºÁúÀ» °¡Áø ¾à¹°.
  • cardioactive agent
    ½É ÀÛ¿ë ¾à, ½ÉÀå ÀÛ¿ë ¾à
    ½ÉÀå¿¡ ´ëÇÑ ÀÛ¿ë È¿°ú ¶Ç´Â Ȱ¼º È¿°ú¸¦ °¡Áö´Â ¾à¹°.
  • cariogenic agent
    ¿ì½Ä À¯¹ß ¿äÀÎ
  • causative agent
    º´¿øÃ¼, ¿øÀÎ ¹°Áú
  • chelating agent
    ŰÀÏ·¹ÀÌÆ® ¾à, ų·¹ÀÌÆ®Á¦
    ±Ý¼Ó À̿°ú °áÇÕÇÏ¿© È­ÇÕ¹°À» »ý¼ºÇÏ´Â ´Ù ¹èÀ§ÀÚ¸¦ °®´Â È­ÇÐ ¹°Áú.
  • chemotherapeutic agent
    È­ÇÐ ¿ä¹ýÁ¦
  • competitive agent
    °æÇÕÁ¦
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
chemotherapeutic agent Chemotherapeutic agents are those medications that are used to treat various forms of cancer. These medications are given in a particular regimen over a period of weeks. most chemotherapeutic medications have the ability to directly kill cancer cells. For this same reason, these medications can suppress the bone marrow to some degree, lowering white blood cell counts. This results in a condition known as immunosuppression and can place the patient at an increased risk of infection.
Examples include busulphan, cisplatin, cyclophosphamide, methotrexate, daunorubicin, doxorubicin, melphalan, vincristine, vinblastine and chlorambucil.
See: immunosuppressive agents.
(27 Sep 1997)
chimpanzee coryza agent <virology> This RNA virus is a member of the Paramyxoviridae family and is a major pathogen in the upper and lower respiratory tract in both infants and younger children.
Respiratory syncytial virus manifestations include bronchiolitis, pneumonia and croup.
Acronym: RSV
(27 Sep 1997)
cholinergic agent An agent that mimics the action of the parasympathetic nervous system (e.g., methacholine).
(05 Mar 2000)
cholinergic parasympathomimetic agent <pharmacology> A chemical substance that causes the release of choline (acetylcholine) from parasympathetic nerve endings.
(15 Jan 1998)
Pittsburgh pneumonia agent A species that causes Pittsburgh pneumonia, a variant of Legionnaires' disease. Accounts for approximately 60% of Legionella pneumonias other than those caused by Legionella pneumophila.
Synonym: Pittsburgh pneumonia agent.
(05 Mar 2000)
contrast agent A substance that is introduced into or around a structure and, because of the difference in absorption of X-rays by the contrast medium and the surrounding tissues, allows radiographic visualisation of the structure.
(18 Nov 1997)
sclerosing agent A compound which acts by irritation of the veinous intimal epithelium; used in the treatment of varicose veins.
(05 Mar 2000)
high osmolar contrast agent Ionic water-soluble iodinated contrast media.
Synonym: high osmolar contrast medium.
(05 Mar 2000)
psychotropic agent A chemical compound that influences the human psyche.
(05 Mar 2000)
narcotic analgesic agent <pharmacology> Medications that relieve pain but have addictive potential if used regularly.
Examples include: meperidine, morphine, propoxyphene, codeine, hydrocodone, oxycodone, hydromorphone, nalbuphine, butorphanol and heroin.
(27 Sep 1997)
neuroleptic agent Any of a family of drugs producing sedation and tranquilization (e.g., chlorpromazine, haloperidol).
See: antipsychotic agent.
Synonym: neuroleptic.
(05 Mar 2000)
Norwalk agent A strain of epidemic gastroenteritis virus that appears to be related to the calciviruses.
Origin: Norwalk, Ohio, where first implicated in disease
(05 Mar 2000)
surface-active agent Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics.
(12 Dec 1998)
delta agent A rare form of viral transfusion hepatitis. A defective viral agent that occurs only in association with hepatitis B infection. The delta agent may also increase the severity of hepatitis B infection. Complications include chronic persistent hepatitis and fulminant hepatitis. A test known as anti-delta agent antibody is positive and used to confirm the diagnosis. Treatment is the same as for hepatitis B.
(27 Sep 1997)
sympathetic agent An agent that evokes responses similar to those produced by adrenergic nerve activity (e.g., epinephrine, ephedrine, isoproterenol).
Synonym: adrenergic amine, adrenomimetic amine, sympathetic amine.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á